Background Alpha-fetoprotein (AFP) expression is closely related to hepatocarcinogenesis,
and it is an important prognostic factor for hepatocellular carcinoma (HCC). We aimed to …

BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

The purpose of this study was to conduct a comprehensive study of the clinical correlation
between the alpha-fetoprotein (AFP) level at diagnosis and pathological grades …

Background and Aims The prognostic ability of α-fetoprotein (AFP) for patients with
hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …

Use of serum alpha-fetoprotein (AFP) in clinical practices has been challenged in recent
years, due to the lack of specificity and sensitivity. Here we conducted a retrospective study …

AIM: To explore the relationship between α-fetoprotein (AFP) and various clinicopathological
variables and different staging system of hepatocellular carcinoma (HCC) thoroughly …

Background Alpha fetoprotein (AFP) is the most widely used tumor marker for hepatocellular
carcinoma (HCC). Nevertheless, few studies have investigated the prognostic factors of …

Alpha fetoprotein (AFP) is the most widely used diagnostic and prognostic serum biomarker
for hepatocellular carcinoma (HCC). Despite its wide clinical use, a systematic …

Background and Objectives: Serum alpha-fetoprotein (AFP) is a recognized affordable
oncological marker in patients with hepatocellular carcinoma (HCC). However, AFP's …